Translocations involving c-myc and c-myc function

[1]  Chi V. Dang,et al.  Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression* , 2001, The Journal of Biological Chemistry.

[2]  F. Alt,et al.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.

[3]  John Calvin Reed,et al.  Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.

[4]  W. Ansorge,et al.  Induction of cyclin E–cdk2 kinase activity, E2F‐dependent transcription and cell growth by Myc are genetically separable events , 2000, The EMBO journal.

[5]  L. Boxer,et al.  NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain Enhancer* , 2000, The Journal of Biological Chemistry.

[6]  C. Dang,et al.  Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Iavarone,et al.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins , 2000, Nature.

[8]  D. Green,et al.  A ‘non-canonical’ DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc , 2000, Current Biology.

[9]  A. Zetterberg,et al.  Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. M. Facchini,et al.  Myc Is an Essential Negative Regulator of Platelet-Derived Growth Factor Beta Receptor Expression , 2000, Molecular and Cellular Biology.

[11]  S. R. Hann,et al.  A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Resar,et al.  HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene , 2000, Molecular and Cellular Biology.

[13]  E. Kandel,et al.  Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis , 2000, Molecular and Cellular Biology.

[14]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[15]  M. Neuberger,et al.  The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line , 2000, Oncogene.

[16]  D. Davies,et al.  Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication , 2000, Oncogene.

[17]  M. Cole,et al.  The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals , 2000, Molecular and Cellular Biology.

[18]  C. Sevignani,et al.  Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA. , 2000, Nucleic acids research.

[19]  M. Gregory,et al.  c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells , 2000, Molecular and Cellular Biology.

[20]  O. Volpert,et al.  An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Larsson,et al.  c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. , 2000, Blood.

[23]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Ken Chen,et al.  Gene-target recognition among members of the Myc superfamily and implications for oncogenesis , 2000, Nature Genetics.

[25]  N. Wittekindt,et al.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU. , 2000, Nucleic acids research.

[26]  T. Yoshizaki,et al.  Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma , 2000, Journal of Cancer Research and Clinical Oncology.

[27]  B. Amati,et al.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. , 2000, Nucleic acids research.

[28]  M. Cole,et al.  The Essential Cofactor TRRAP Recruits the Histone Acetyltransferase hGCN5 to c-Myc , 2000, Molecular and Cellular Biology.

[29]  P. L. Bergsagel,et al.  Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Eisenman,et al.  The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.

[31]  E. Gabrielson,et al.  c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. , 2000, Cancer research.

[32]  R. Eisenman,et al.  c-Myc enhances protein synthesis and cell size during B lymphocyte development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[34]  M. Brüggemann,et al.  B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu). , 1999, Cancer research.

[35]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[36]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[37]  D. Prober,et al.  Drosophila myc Regulates Cellular Growth during Development , 1999, Cell.

[38]  C. Dang,et al.  c-Myc Overexpression Uncouples DNA Replication from Mitosis , 1999, Molecular and Cellular Biology.

[39]  C. Dang,et al.  Neoplastic Transformation of RK3E by Mutant β-Catenin Requires Deregulation of Tcf/Lef Transcription but Not Activation of c-myc Expression , 1999, Molecular and Cellular Biology.

[40]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[41]  John M. Sedivy,et al.  c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.

[42]  K. Wennerberg,et al.  β1 integrin promotes but is not essential for metastasis of ras-myc transformed fibroblasts , 1999, Oncogene.

[43]  G. Evan,et al.  c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.

[44]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[45]  Emmett V Schmidt,et al.  The role of c-myc in cellular growth control , 1999, Oncogene.

[46]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[47]  G. Evan,et al.  Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. , 1999, Molecular cell.

[48]  W. Franke,et al.  Dante's Interpretive Journey@@@Dante and Governance , 1999 .

[49]  A. Polack,et al.  Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma , 1999, Oncogene.

[50]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[51]  E. Prochownik,et al.  C-myc overexpression and p53 loss cooperate to promote genomic instability , 1999, Oncogene.

[52]  G. Semenza,et al.  Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.

[53]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[54]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[55]  Kou-Juey Wu,et al.  Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. , 1999, Science.

[56]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[57]  G. Evan,et al.  The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis , 1998, Oncogene.

[58]  C. Dang,et al.  Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. , 1998, Cancer research.

[59]  L. Gerace,et al.  All Four Homochiral Enantiomers of a Nuclear Localization Sequence Derived from c-Myc Serve as Functional Import Signals* , 1998, The Journal of Biological Chemistry.

[60]  L. Madisen,et al.  The Immunoglobulin Heavy Chain Locus Control Region Increases Histone Acetylation along Linked c-myc Genes , 1998, Molecular and Cellular Biology.

[61]  Q. Zhan,et al.  Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents , 1998, Oncogene.

[62]  C. Busch,et al.  myc Boxes, Which Are Conserved in myc Family Proteins, Are Signals for Protein Degradation via the Proteasome , 1998, Molecular and Cellular Biology.

[63]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[64]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[65]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[66]  E. Prochownik,et al.  Commonly occurring loss and mutation of the MXI1 gene in prostate cancer , 1998, Genes, chromosomes & cancer.

[67]  G. Hannon,et al.  Myc activates telomerase. , 1998, Genes & development.

[68]  R. DePinho,et al.  Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth , 1998, Nature.

[69]  R. Eisenman,et al.  Sequential expression of the MAD family of transcriptional repressors during differentiation and development , 1998, Oncogene.

[70]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  B. Amati,et al.  Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.

[72]  T. Lee,et al.  Myc represses transcription of the growth arrest gene gas1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  W. Ansorge,et al.  Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes , 1997, Oncogene.

[74]  G. Evan,et al.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. , 1997, Science.

[75]  D. Wechsler,et al.  MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. , 1997, Cancer research.

[76]  J. Sedivy,et al.  Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[77]  C. Dang,et al.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene , 1997, Molecular and cellular biology.

[78]  B. Amati,et al.  Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.

[79]  M. Eilers,et al.  Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases , 1997, Oncogene.

[80]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Hengstschläger,et al.  Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. , 1997, DNA and cell biology.

[82]  Andreas Sewing,et al.  Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes , 1997, Oncogene.

[83]  M. Brüggemann,et al.  Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC , 1997, Oncogene.

[84]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[85]  G. D. Spotts,et al.  Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins , 1997, Molecular and cellular biology.

[86]  R. DePinho,et al.  Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[87]  B. Amati,et al.  Growth arrest by the cyclin‐dependent kinase inhibitor p27Kip1 is abrogated by c‐Myc. , 1996, The EMBO journal.

[88]  R. Eisenman,et al.  Myc and Max Homologs in Drosophila , 1996, Science.

[89]  R. Eisenman,et al.  Mad proteins contain a dominant transcription repression domain , 1996, Molecular and cellular biology.

[90]  D. Beach,et al.  Cdc25 cell-cycle phosphatase as a target of c-myc , 1996, Nature.

[91]  O. Yanuka,et al.  ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[92]  K. Klempnauer,et al.  A novel function for Myc: inhibition of C/EBP-dependent gene activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[93]  M. Roussel,et al.  Inhibition of cell proliferation by the Mad1 transcriptional repressor , 1996, Molecular and cellular biology.

[94]  C. Dang,et al.  A link between c-Myc-mediated transcriptional repression and neoplastic transformation. , 1996, The Journal of clinical investigation.

[95]  R. DePinho,et al.  Expression and activity of L-Myc in normal mouse development , 1996, Molecular and cellular biology.

[96]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[97]  G. Hart,et al.  c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.

[98]  M. Raffeld,et al.  A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain , 1995, Molecular and cellular biology.

[99]  L. Boxer,et al.  The Transcription Factor, Nm23H2, Binds to and Activates the Translocated c-myc Allele in Burkitt's Lymphoma (*) , 1995, The Journal of Biological Chemistry.

[100]  P. Farnham,et al.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants , 1995, Molecular and cellular biology.

[101]  S Gaubatz,et al.  Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.

[102]  J. Michaelson,et al.  Identification of 3α-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation , 1995 .

[103]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[104]  L. Boxer,et al.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma , 1994, Molecular and cellular biology.

[105]  L. Madisen,et al.  Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. , 1994, Genes & development.

[106]  G. Prendergast,et al.  c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. , 1994, The EMBO journal.

[107]  J. Cleveland,et al.  Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.

[108]  Liang Zhu,et al.  Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation. , 1994, The EMBO journal.

[109]  S. Baldwin,et al.  Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line , 1994, The Journal of experimental medicine.

[110]  B. Lutterbach,et al.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis , 1994, Molecular and cellular biology.

[111]  S. Mai,et al.  c-Myc binds to 5' flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation. , 1994, Nucleic acids research.

[112]  R. DePinho,et al.  Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[113]  C. Dang,et al.  Binding and suppression of the Myc transcriptional activation domain by p107. , 1994, Science.

[114]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[115]  A. Polack,et al.  Regulatory elements in the immunoglobulin kappa locus induce c‐myc activation and the promoter shift in Burkitt's lymphoma cells. , 1993, The EMBO journal.

[116]  I. Magrath,et al.  Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas , 1993, Nature Genetics.

[117]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Chaganti,et al.  Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24 , 1993, Genes, chromosomes & cancer.

[119]  K. Isselbacher,et al.  Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[120]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[121]  B. S. Yang,et al.  Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo , 1993, Molecular and cellular biology.

[122]  A. Bradley,et al.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. , 1993, Genes & development.

[123]  V. Rotter,et al.  c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[124]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[125]  A. Perkins,et al.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. , 1992, Genes & development.

[126]  E. E. Max,et al.  Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints , 1992, Molecular and cellular biology.

[127]  M. Groudine,et al.  The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. , 1992, Genes & development.

[128]  K. Siminovitch,et al.  Nucleotide sequence of the intron of the germline human kappa immunoglobulin gene connecting the J and C regions reveals a matrix association region (MAR) next to the enhancer. , 1992, Nucleic acids research.

[129]  D. Eick,et al.  Hold back of RNA polymerase II at the transcription start site mediates down‐regulation of c‐myc in vivo. , 1992, The EMBO journal.

[130]  G. D. Spotts,et al.  Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation. , 1992, Genes & development.

[131]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[132]  G. Prendergast,et al.  A new bind for Myc. , 1992, Trends in genetics : TIG.

[133]  C. Dang,et al.  Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[134]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[135]  C. Dang,et al.  Max: functional domains and interaction with c-Myc. , 1992, Genes & development.

[136]  B. de Crombrugghe,et al.  Transcriptional suppression of cellular gene expression by c-Myc , 1991, Molecular and cellular biology.

[137]  P. Levine,et al.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. , 1991, Blood.

[138]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[139]  M. Groudine,et al.  Control of c-myc regulation in normal and neoplastic cells. , 1991, Advances in cancer research.

[140]  G. Inghirami,et al.  Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. , 1990, Science.

[141]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[142]  M. Reth,et al.  A physical map and analysis of the murine Cχ‐RS region show the presence of a conserved element , 1990 .

[143]  M. Neuberger,et al.  A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus , 1990, Nature.

[144]  I. Magrath.  The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.

[145]  P. Leder,et al.  A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice , 1988, Nature.

[146]  A. Polack,et al.  The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation. , 1988, Oncogene.

[147]  C. Dang,et al.  Identification of the human c-myc protein nuclear translocation signal , 1988, Molecular and cellular biology.

[148]  M. Groudine,et al.  Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. , 1987, Science.

[149]  E. Newcomb,et al.  Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts , 1987, Cell.

[150]  D. Eick,et al.  Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. , 1986, Nucleic acids research.

[151]  K. Marcu,et al.  Intragenic pausing and anti‐sense transcription within the murine c‐myc locus. , 1986, The EMBO journal.

[152]  Mark Groudine,et al.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.

[153]  R. Weinberg,et al.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.

[154]  P. Pelicci,et al.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[155]  S. Cory.  Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. , 1986, Advances in cancer research.

[156]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[157]  T. Littlewood,et al.  Chromatin structure of transcriptionally active and inactive human c‐myc alleles. , 1985, The EMBO journal.

[158]  T. Rabbitts,et al.  Chromatin structure around the c-myc gene in Burkitt lymphomas with upstream and downstream translocation points. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[159]  T. Rabbitts,et al.  Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma , 1984, Nature.

[160]  P. Leder,et al.  Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphoma , 1984, Cell.

[161]  P. Leder,et al.  Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells , 1984, Cell.

[162]  W. S. Hayward,et al.  Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus , 1984, Nature.

[163]  S. Cory,et al.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. , 1983, The EMBO journal.

[164]  P. Leder,et al.  Translocations among antibody genes in human cancer. , 1983, Science.

[165]  J Erikson,et al.  Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.

[166]  C. Croce,et al.  Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[167]  J Erikson,et al.  Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.